Inhibition of PCSK9: A Promising Enhancer for Anti-PD-1/PD-L1 Immunotherapy.
Sun S, Ma J, Zuo T, Shi J, Sun L, Meng C, Shu W, Yang Z, Yao H, Zhang Z.
Sun S, et al. Among authors: zuo t.
Research (Wash D C). 2024 Sep 25;7:0488. doi: 10.34133/research.0488. eCollection 2024.
Research (Wash D C). 2024.
PMID: 39324018
Free PMC article.
Review.